OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)
| 10.50 Data as of May 17 |  +0.08 / +0.77%Today’s Change | 9.16 Today|||52-Week Range 14.99 | -19.97% Year-to-Date |
Latest OGXI News | Press Releases
| OncoGenex Loss Lower than Expected - Analyst Blog May 06 / Zacks.com |
Today’s Trading
| Previous close | 10.42 |
| Today’s open | 10.50 |
| Day’s range | 10.45 - 10.55 |
| Volume | 85,257 |
| Average volume (3 months) | 68,344 |
| Market cap | $154.0M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | -3.31% |
| Earnings growth (this year) | -15.79% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +265.63% |
| P/E ratio | NM |
| Price/Sales | 8.83 |
| Price/Book | 2.32 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OMEROmeros Corp | +0.05 | +0.98% |
| MEIPMEI Pharma Inc | -0.07 | -0.78% |
| AVEOAveo Pharmaceuticals... | +0.20 | +7.12% |
| HZNPHorizon Pharma Inc | -0.01 | -0.41% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | -$0.61 |
| Annual revenue (last year) | $20.1M |
| Annual profit (last year) | -$21.1M |
| Net profit margin | -104.99% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, CEO, CFO, Secretary & Treasurer Scott Daniel Cormack |
Chief Medical Officer & Executive Vice President Cindy A. Jacobs, MD, PhD |
Corporate headquarters Bothell, Washington |
Forecasts
